Testing effectiveness (Phase 2)Study completedNCT03733314What this trial is testingE6011 in Participants With Active Crohn's DiseaseWho this might be right forCrohn's Disease EA Pharma Co., Ltd. 25
Testing effectiveness (Phase 2)Study completedNCT03681067What this trial is testingA Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn Disease University of Birmingham 5
Post-approval studies (Phase 4)WithdrawnNCT00672763What this trial is testingAdjuvant Vitamin D With Corticosteroids in Active Crohn's DiseaseWho this might be right forCrohn's Disease Imperial College London
Post-approval studies (Phase 4)UnknownNCT05456932What this trial is testingPredicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel DiseaseWho this might be right forInflammatory Bowel DiseasesIron-deficiencyIron Deficiency Anemia Leiden University Medical Center 90
Large-scale testing (Phase 3)Looking for participantsNCT06227910What this trial is testingVedolizumab With and Without Upadacitinib in Adults With Crohn's DiseaseWho this might be right forCrohn's Disease Takeda 396
Not applicableLooking for participantsNCT07471438What this trial is testingConcordance Between Inflammatory Activity Assessed by Enteric MRI With and Without Intestinal Distension Product in Patients With Ileal Crohn's Disease.Who this might be right forCrohn Disease (CD) University Hospital, Clermont-Ferrand 60
Early research (Phase 1)Ended earlyNCT03169894What this trial is testingEvaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative ColitisWho this might be right forCrohn DiseaseUlcerative Colitis Avalo Therapeutics, Inc. 8
Large-scale testing (Phase 3)Study completedNCT03926130What this trial is testingMirikizumab (LY3074828) in Participants With Crohn's DiseaseWho this might be right forCrohn's Disease Eli Lilly and Company 1,158
Not applicableUnknownNCT03054935What this trial is testingResting Energy Expenditure Evaluation in Subjects With Crohn's DiseaseWho this might be right forCrohn Disease Fabrizio Pasanisi 150
Testing effectiveness (Phase 2)Study completedNCT00528073What this trial is testingPlacebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's DiseaseWho this might be right forCrohn's Disease Alfasigma S.p.A. 410
Not applicableStudy completedNCT01697761What this trial is testingEfficacy of Acupuncture and Moxibustion Treatment in Patients With Active Crohn's DiseaseWho this might be right forCrohn's DiseaseCAM Shanghai Institute of Acupuncture, Moxibustion and Meridian 92
Testing effectiveness (Phase 2)UnknownNCT02000362What this trial is testingSafety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)Who this might be right forCrohn's Disease Kang Stem Biotech Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT00101946What this trial is testingNine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease GlaxoSmithKline 17
Not applicableUnknownNCT04736368What this trial is testingEffect of EDIP Based Diet on CD ActivityWho this might be right forCrohn Disease First Affiliated Hospital of Zhejiang University 200
Large-scale testing (Phase 3)Looking for participantsNCT05837897What this trial is testingVedolizumab in Adult Participants With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease Takeda 408
Not applicableLooking for participantsNCT06756100What this trial is testingEarly Inflammatory Bowel Disease ProgressionWho this might be right forInflammatory Bowel DiseasesCrohn Disease (CD)Ulcerative Colitis (UC) Pontificia Universidad Catolica de Chile 140
Not applicableStudy completedNCT02887287What this trial is testingEfficacy of Exclusive Enteral Nutrition in Adult Active Crohn's DiseaseWho this might be right forEfficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease With Complications or Failure of Medical Treatment Sun Yat-sen University 48
Not applicableStudy completedNCT01338740What this trial is testingSwitching From Adalimumab to InfliximabWho this might be right forCrohn's Disease University Hospital, Ghent 21
Not applicableStudy completedNCT04956991What this trial is testingCT Diagnoses in Crohn"s Disease ActivityWho this might be right forCrohn's Disease Peking University Third Hospital 35
Testing effectiveness (Phase 2)Study completedNCT02365649What this trial is testingA Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF TherapyWho this might be right forCrohn's Disease AbbVie 220